Bromide

Bromide

SCHEMBL368454

Br.Br.C=CC[N+](CC=C)(CC=C)CC=C.[Br-]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL28874797 0.96
Bromide SCHEMBL368455 0.96 TSHR (0.31)
Bromide SCHEMBL463372 0.96 TSHR (0.31)
Bromide SCHEMBL368453 0.96 TSHR (0.31)
Hydrogen Sulfide SCHEMBL28090943 0.92 TSHR (0.33)
SCHEMBL197824 0.92 TSHR (0.33)
Fluoride Ion SCHEMBL1260645 0.88 TSHR (0.31)
Hydrochloric Acid SCHEMBL20896 0.88 TSHR (0.31)
SCHEMBL596385 0.88 TSHR (0.31)
Lithium Ion SCHEMBL2504315 0.88 TSHR (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 170 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230174687-A1 PROCESS FOR THE PREPARATION OF BROMINATED COPOLYMERS OF CONJUGATED DIENES AND STYRENIC MONOMERS LANXESS CORPORATION (US) 2023-06-08 US claimed
US-8779066-B2 Process for brominating butadiene polymers using ester solvent mixtures DOW GLOBAL TECHNOLOGIES LLC (US) 2014-07-15 US claimed
US-20140121330-A1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES THE DOW CHEMICAL COMPANY 2014-05-01 US claimed
EP-2379605-B1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES DOW GLOBAL TECHNOLOGIES LLC (US) 2014-03-12 EP claimed
US-8410226-B2 Two-step process for brominating butadiene copolymers DOW GLOBAL TECHNOLOGIES LLC (US) 2013-04-02 US claimed
EP-2274338-B1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES LLC (US) 2012-12-12 EP claimed
US-8193287-B2 Process for brominating butadiene copolymers by the addition of water or certain solvents DOW GLOBAL TECHNOLOGIES LLC (US) 2012-06-05 US claimed
JP-2011528380-A 2011-11-17 JP claimed
EP-2379605-A1 PROCESS FOR BROMINATING BUTADIENE POLYMERS USING ESTER SOLVENT MIXTURES Dow Global Technologies LLC (US) 2011-10-26 EP claimed
JP-4726778-B2 2011-07-20 JP claimed
US-20100004402-A1 Process for brominating butadiene/vinyl aromatic copolymers THE DOW CHEMICAL COMPANY 2010-01-07 US claimed
WO-2009139942-A2 PROCESS FOR BROMINATING BUTADIENE COPOLYMERS BY THE ADDITION OF WATER OR CERTAIN SOLVENTS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-19 WO claimed
WO-2009134628-A1 TWO-STEP PROCESS FOR BROMINATING BUTADIENE COPOLYMERS DOW GLOBAL TECHNOLOGIES INC. (US) 2009-11-05 WO claimed
US-7605267-B2 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2009-10-20 US claimed
EP-2054445-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS Dow Global Technologies Inc. (US) 2009-05-06 EP claimed
WO-2008021417-A2 PROCESS FOR BROMINATING BUTADIENE/VINYL AROMATIC COPOLYMERS DOW GLOBAL TECHNOLOGIES, INC. (US) 2008-02-21 WO claimed
JP-2006522055-A 2006-09-28 JP claimed
US-20060189653-A1 Process for the preparation of 5-(halocetyl)-8-(substituted oxy)-(1h)-quinolin-2-ones NOVARTIS AG (CH) 2006-08-24 US claimed
EP-1613599-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES Novartis AG (CH) 2006-01-11 EP claimed
WO-2004087668-A1 A PROCESS FOR THE PREPARATION OF 5-(HALOACETYL)-8-(SUBSTITUTED OXY)-(1H)-QUINOLIN-2-ONES NOVARTIS AG (CH) 2004-10-14 WO claimed